Kambiz Thomas Moazed

US Patent:

20020032400, Mar 14, 2002

Filed:

May 22, 2001

Appl. No.:

09/862744

Inventors:

Kambiz Moazed - New York NY, US

International Classification:

A61M005/00

US Classification:

604/008000

Abstract:

A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a silastic tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a silastic tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the silastic tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the silastic tube are then fastened to the attachment element of the insert. Excess tube extending into the nasal cavity is then cut short to reduce nasal irritation. After the hole has sufficiently healed in about 3-6 months, the silastic tube and the insert are removed.

US Patent:

20030130612, Jul 10, 2003

Filed:

Feb 25, 2003

Appl. No.:

10/373508

Inventors:

Kambiz Moazed - New York NY, US

International Classification:

A61M005/00

US Classification:

604/008000

Abstract:

A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a silastic tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a silastic tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the silastic tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the silastic tube are then fastened to the attachment element of the insert. Excess tube extending into the nasal cavity is then cut short to reduce nasal irritation. After the hole has sufficiently healed in about 3-6 months, the silastic tube and the insert are removed.

US Patent:

20110280909, Nov 17, 2011

Filed:

Jan 29, 2010

Appl. No.:

13/138260

Inventors:

Kambiz Thomas Moazed - New York NY, US

International Classification:

A61K 31/05
A61K 31/13
A61K 31/138
A61K 31/541
A61K 31/136
A61K 31/4178
A61K 31/47
A61K 31/485
A61K 31/7105
A61K 39/08
A61K 31/191
A61K 36/62
A61K 31/655
A61P 27/06
A61P 35/00
A61K 31/352

US Classification:

4242391, 514731, 514456, 514733, 514662, 514651, 5142278, 514648, 514397, 514734, 514307, 514282, 514 44 A, 514455, 514557, 424778, 514150

Abstract:

Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening the pigmented tissues or treating a pigmented tissue related disease.

US Patent:

20120076848, Mar 29, 2012

Filed:

Jul 21, 2010

Appl. No.:

13/261047

Inventors:

Kambiz Thomas Moazed - New York NY, US

International Classification:

A61K 9/00
A61K 31/352
A61K 31/222
A61K 31/541
A61K 31/196
A61K 31/4178
A61K 31/472
A61K 31/485
A61K 31/13
A61K 31/713
A61K 38/16
A61K 36/185
A61K 31/23
A61K 31/557
A61K 31/655
A61K 31/136
C07F 3/06
A61P 27/02
A61P 43/00
A61P 27/06
A61P 35/00
A61K 31/05
B82Y 5/00

US Classification:

424427, 514731, 514733, 514456, 514546, 5142278, 514567, 514397, 514734, 514307, 514282, 514662, 514 44 A, 514 208, 514455, 424778, 514547, 514573, 514150, 514454, 514641, 556130, 977773, 977906

Abstract:

Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening the pigmented tissues or treating a pigmented tissue related disease.

US Patent:

20120207809, Aug 16, 2012

Filed:

Nov 30, 2011

Appl. No.:

13/373797

Inventors:

Kambiz Thomas Moazed - New York NY, US

International Classification:

A61K 9/00
A61K 39/08
A61K 33/26
A61K 33/24
A61K 31/7088
A61K 31/13
A61K 31/05
A61P 27/06
A61P 35/00
A61P 27/02
A61K 8/40
A61K 31/352
B82Y 5/00

US Classification:

424427, 424 62, 4242391, 424641, 424646, 424649, 514 44 A, 514454, 514662, 514731, 977773, 977906

Abstract:

Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.

US Patent:

59934077, Nov 30, 1999

Filed:

Oct 25, 1996

Appl. No.:

8/736902

Inventors:

Kambiz Thomas Moazed - New York NY

International Classification:

A61M 500

US Classification:

604 8

Abstract:

A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the tube are then fastened to the attachment element of the insert.

US Patent:

20190142940, May 16, 2019

Filed:

Aug 3, 2017

Appl. No.:

15/731805

Inventors:

Kambiz Thomas Moazed - New York NY, US

International Classification:

A61K 45/06
A61Q 1/00
A61K 33/26
A61K 33/24
A61K 31/7088
A61K 9/00
A61K 31/13
A61K 31/05
A61K 31/352

Abstract:

Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.